960 x 350_41

Diabetes Solutions

Accelerate your diabetes research

With the prevalence of diabetes expected to increase, you need one global partner to accelerate your diabetes research from discovery to post-market. At Q2 Solutions, we offer a complete range of diabetes drug development solutions including central, bioanalytical, ADME and genomic testing and biomarker services – plus support for companion diagnostic studies for personalized medicine.

 

We also provide support for the full spectrum of diabetic complications: cardiac and vascular pathology due to systemic inflammation; as well as, renal, retinal and neuropathies due to the interactions of numerous cytokines, chemokines and oxidative stress markers. Our diabetes experts work with pharmaceutical scientists to design and support the best panels of unique biomarkers for the diagnosis and treatment of these underserved complications.

 

Our lab experience includes testing services in support of clinical trials for insulins, GLP-1/glucagon dual-agonists, SGLT2 inhibitors, DPP-4 inhibitors (gliptins), combination therapies and more. See our factsheet to learn more about our broad range of testing services and capabilities for diabetes studies.

 

We participate in many proficiency and certification programs for endocrine testing, such as:

 

  • The NLipid Standardization Program
  • CAP Proficiency Scheme
  • We are National Glycohemoglobin Standardization Program (NGSP)
  • CDC a member of the ADA, AACC, IFCC and IDF.

 

Our industry renowned scientific experts are here to help you navigate today’s increasingly complex drug development programs.

Q2 Solutions offers clinical trial testing services for insulins, GLP-1/glucagon dual-agonists, SGLT2 inhibitors, DPP-4 inhibitors (gliptins), combination therapies and more

Related Thought Leaders Insights

Scientific Poster

Robust performance of single-cell multiomic analysis (CITE-Seq) demonstrated across multiple locations, replicates, and donors on challenging cryopreserved PBMC and BMMC samples

Q2 Solutions is the first and only service provider to achieve the exclusive certified service partnership for CITE-Seq scRNA-Seq with BioLegend. Describes CITE-Seq performance expectations for...

Brochure

Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Factsheet

CNS Biomarkers

Rules-Based Medicine, a Q2 Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...